Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Industrials · Wholesale-Industrial Machinery & Equipment

DNOW Inc. to acquire MRC Global Inc.

Announced Jun 26, 2025 · Closed Nov 6, 2025

Deal value$1.50BEV $1.50B
Premium—To unaffected price
EV / Adj. EBITDA9.9x0.5x EV / Revenue
ConsiderationAll stock$13.85 per share

Transaction

Acquirer
DNOW Inc. (DNOW)
Target
MRC Global Inc. (MRC)
Buyer type
Strategic
Offer price per share
$13.85
Enterprise value
$1.50B
Status
Closed Nov 6, 2025

Deal protections

Break fee (target pays)
$45.5M · 3.0%
Reverse fee (buyer pays)
$45.5M · 3.0%
Go-shop
No-shop
Financing
Committed · Goldman Sachs

Advisors

To the acquirer
Goldman Sachs
To the target
JPMorgan
Goldman Sachs fee
$3.0M
JPMorgan fee
$23.0M

Sector context · Industrials

Comparable deals
89 in the prior 24 months
Premium
Sector median 39.5%
EV / Adj. EBITDA
9.9x vs. 9.1x sector median
Break fee
3.0% vs. 2.7% sector median

Timeline

  1. AnnouncedJun 26, 2025
  2. Proxy filedAug 5, 2025
  3. Definitive proxyAug 5, 2025
  4. Shareholder voteSep 9, 2025
  5. ClosedNov 6, 2025

Valuation · fairness opinions

Discounted cash flowGoldman Sachs$15.70$18.66
Discounted cash flowGoldman Sachs$15.60$19.39
Discounted cash flowGoldman Sachs$17.15$20.92
Future share priceGoldman Sachs$15.44$17.46
Future share priceGoldman Sachs$13.66$16.78
Discounted cash flowJPMorgan$14.50$22.30
Discounted cash flowJPMorgan$15.80$21.90
Offer $13.85

Implied value per MRC Global Inc. share by analysis, from Goldman Sachs and JPMorgan · DCF discount rate 10%–12%.

Sources
  • 8-K (EX-99.1) · Jun 26, 2025
  • 425 · Jun 26, 2025
  • 425 · Jun 26, 2025
  • 425 · Jun 27, 2025

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.